Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

XXIV.i

Progression, acceleration or exacerbation of preexisting ILD/fibrosis

(Fr: aggravation d'une Pn interstitielle préexistante). The preexistinf ILD can be idiopathic pulmonary fibrosis (IPF), rheumatoid lung, CTD-related or any kind of ILD/pulmonary fibrosis. Can cause acute fatal respiratory failure in 25-30% of those affected. See also Iw.

Publications

Wendling D, Vidon C, Godfrin-Valnet M, Rival G, Guillot X, Prati C

Exacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis.

Joint, bone, spine : revue du rhumatisme 2013 Dec;80;670-1 — 2013 Dec — 670-1

Kawashiri SY, Kawakami A, Sakamoto N, Ishimatsu Y, Eguchi K

A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab.

Rheumatology international 2012 Dec;32;4023-6 — 2012 Dec — 4023-6